• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞清道夫受体:肿瘤支持与肿瘤抑制

Macrophage scavenger receptors: Tumor support and tumor inhibition.

作者信息

Kazakova Elena, Iamshchikov Pavel, Larionova Irina, Kzhyshkowska Julia

机构信息

Laboratory of translational cellular and molecular biomedicine, National Research Tomsk State University, Tomsk, Russia.

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

出版信息

Front Oncol. 2023 Jan 6;12:1096897. doi: 10.3389/fonc.2022.1096897. eCollection 2022.

DOI:10.3389/fonc.2022.1096897
PMID:36686729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9853406/
Abstract

Tumor-associated macrophages (TAMs) are a heterogeneous population of myeloid cells that constitute up to 50% of the cell mass of human tumors. TAMs interact with the components of the tumor microenvironment (TME) by using scavenger receptors (SRs), a large superfamily of multifunctional receptors that recognize, internalize and transport to the endosomal/lysosomal pathway apoptotic cells, cytokines, matrix molecules, lipid modified lipoproteins and other unwanted-self ligands. In our review, we summarized state-of-the art for the role of macrophage scavenger receptors in tumor development and their significance as cancer biomarkers. In this review we focused on functional activity of TAM-expressing SRs in animal models and in patients, and summarized the data for different human cancer types about the prognostic significance of TAM-expressed SRs. We discussed the role of SRs in the regulation of cancer cell biology, cell-cell and cell-matrix interaction in TME, immune status in TME, angiogenesis, and intratumoral metabolism. Targeting of tumor-promoting SRs can be a promising therapeutic approach in anti-cancer therapy. In our review we provide evidence for both tumor supporting and tumor inhibiting functions of scavenger receptors expressed on TAMs. We focused on the key differences in the prognostic and functional roles of SRs that are specific for cancer types. We highlighted perspectives for inhibition of tumor-promoting SRs in anti-cancer therapy.

摘要

肿瘤相关巨噬细胞(TAM)是一类异质性髓样细胞群体,在人类肿瘤的细胞组成中占比高达50%。TAM通过清道夫受体(SR)与肿瘤微环境(TME)的成分相互作用,SR是一个多功能受体的大家族,可识别、内化并将凋亡细胞、细胞因子、基质分子、脂质修饰脂蛋白及其他有害的自身配体转运至内体/溶酶体途径。在我们的综述中,我们总结了巨噬细胞清道夫受体在肿瘤发展中的作用及其作为癌症生物标志物的意义。在本综述中,我们重点关注了在动物模型和患者中表达SR的TAM的功能活性,并总结了不同人类癌症类型中TAM表达的SR的预后意义的数据。我们讨论了SR在调节癌细胞生物学、TME中的细胞-细胞和细胞-基质相互作用、TME中的免疫状态、血管生成及肿瘤内代谢方面的作用。靶向促进肿瘤生长的SR可能是抗癌治疗中一种有前景的治疗方法。在我们的综述中,我们提供了TAM上表达的清道夫受体具有肿瘤支持和肿瘤抑制功能的证据。我们重点关注了特定癌症类型中SR在预后和功能作用方面的关键差异。我们强调了在抗癌治疗中抑制促进肿瘤生长的SR的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/4d66de0c4de0/fonc-12-1096897-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/8b7ed655dd1d/fonc-12-1096897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/c407b97fd205/fonc-12-1096897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/8bc228d94cbc/fonc-12-1096897-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/4d66de0c4de0/fonc-12-1096897-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/8b7ed655dd1d/fonc-12-1096897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/c407b97fd205/fonc-12-1096897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/8bc228d94cbc/fonc-12-1096897-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998b/9853406/4d66de0c4de0/fonc-12-1096897-g004.jpg

相似文献

1
Macrophage scavenger receptors: Tumor support and tumor inhibition.巨噬细胞清道夫受体:肿瘤支持与肿瘤抑制
Front Oncol. 2023 Jan 6;12:1096897. doi: 10.3389/fonc.2022.1096897. eCollection 2022.
2
The role of tumor-associated macrophage in breast cancer biology.肿瘤相关巨噬细胞在乳腺癌生物学中的作用。
Histol Histopathol. 2018 Feb;33(2):133-145. doi: 10.14670/HH-11-916. Epub 2017 Jul 6.
3
Role of macrophage scavenger receptors in atherosclerosis.清道夫受体在动脉粥样硬化中的作用。
Immunobiology. 2012 May;217(5):492-502. doi: 10.1016/j.imbio.2012.02.015. Epub 2012 Mar 2.
4
Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.清道夫受体:在癌症生物学和免疫学中的新作用。
Adv Cancer Res. 2015;128:309-64. doi: 10.1016/bs.acr.2015.04.004. Epub 2015 Jun 17.
5
Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.基于 M2 样肿瘤相关巨噬细胞靶向纳米复合物的肿瘤微环境重塑与肿瘤治疗。
Theranostics. 2021 Jan 1;11(6):2892-2916. doi: 10.7150/thno.50928. eCollection 2021.
6
Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.通过重编程肿瘤相关巨噬细胞开发的基于纳米医学的癌症免疫疗法。
Nanoscale. 2021 Mar 12;13(9):4705-4727. doi: 10.1039/d0nr08050k.
7
Targeting tumor-associated macrophages as an antitumor strategy.靶向肿瘤相关巨噬细胞作为一种抗肿瘤策略。
Biochem Pharmacol. 2021 Jan;183:114354. doi: 10.1016/j.bcp.2020.114354. Epub 2020 Dec 3.
8
Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.肿瘤相关巨噬细胞:癌症免疫治疗策略的有前途的靶点。
Pharmacol Res. 2020 Nov;161:105111. doi: 10.1016/j.phrs.2020.105111. Epub 2020 Oct 13.
9
Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial context.人类癌症中的巨噬细胞多样性:单细胞分辨率和空间背景提供的新见解
Heliyon. 2024 Mar 21;10(7):e28332. doi: 10.1016/j.heliyon.2024.e28332. eCollection 2024 Apr 15.
10
Targeting macrophages: a novel treatment strategy in solid tumors.靶向巨噬细胞:实体瘤治疗的新策略。
J Transl Med. 2022 Dec 12;20(1):586. doi: 10.1186/s12967-022-03813-w.

引用本文的文献

1
Polarization of Tumor Cells and Tumor-Associated Macrophages: Molecular Mechanisms and Therapeutic Targets.肿瘤细胞与肿瘤相关巨噬细胞的极化:分子机制与治疗靶点
MedComm (2020). 2025 Sep 1;6(9):e70372. doi: 10.1002/mco2.70372. eCollection 2025 Sep.
2
Lipid Metabolism Reprogramming in Cancer: Insights into Tumor Cells and Immune Cells Within the Tumor Microenvironment.癌症中的脂质代谢重编程:对肿瘤微环境中肿瘤细胞和免疫细胞的见解
Biomedicines. 2025 Aug 4;13(8):1895. doi: 10.3390/biomedicines13081895.
3
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages.

本文引用的文献

1
Monocyte programming by cancer therapy.癌症治疗对单核细胞的编程作用。
Front Immunol. 2022 Oct 20;13:994319. doi: 10.3389/fimmu.2022.994319. eCollection 2022.
2
A study on the correlation between M2 macrophages and regulatory T cells in the progression of colorectal cancer.M2 巨噬细胞与调节性 T 细胞在结直肠癌进展中的相关性研究。
Int J Biol Markers. 2022 Dec;37(4):412-420. doi: 10.1177/03936155221132572. Epub 2022 Oct 26.
3
Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases.
钠-葡萄糖协同转运蛋白2抑制剂的抗炎作用:聚焦于巨噬细胞
Int J Mol Sci. 2025 Feb 15;26(4):1670. doi: 10.3390/ijms26041670.
4
Targeting immune checkpoints on myeloid cells: current status and future directions.靶向髓系细胞上的免疫检查点:现状与未来方向。
Cancer Immunol Immunother. 2025 Jan 3;74(2):40. doi: 10.1007/s00262-024-03856-6.
5
Targeting of TAMs: can we be more clever than cancer cells?靶向肿瘤相关巨噬细胞:我们能否比癌细胞更聪明?
Cell Mol Immunol. 2024 Dec;21(12):1376-1409. doi: 10.1038/s41423-024-01232-z. Epub 2024 Nov 8.
6
Detailed role of SR-A1 and SR-E3 in tumor biology, progression, and therapy.清道夫受体 A1 和 E3 在肿瘤生物学、进展和治疗中的详细作用。
Cell Biochem Biophys. 2024 Sep;82(3):1735-1750. doi: 10.1007/s12013-024-01350-5. Epub 2024 Jun 17.
7
Clinical landscape of macrophage-reprogramming cancer immunotherapies.巨噬细胞重编程癌症免疫疗法的临床现状。
Br J Cancer. 2024 Sep;131(4):627-640. doi: 10.1038/s41416-024-02715-6. Epub 2024 Jun 3.
8
Modelling of macrophage responses to biomaterials : state-of-the-art and the need for the improvement.巨噬细胞对生物材料反应的建模:现状和改进的需要。
Front Immunol. 2024 Mar 26;15:1349461. doi: 10.3389/fimmu.2024.1349461. eCollection 2024.
9
Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers.前列腺癌:遗传学、表观遗传学和免疫生物标志物的需求。
Int J Mol Sci. 2023 Aug 14;24(16):12797. doi: 10.3390/ijms241612797.
10
Targeting reactive oxygen species and fat acid oxidation for the modulation of tumor-associated macrophages: a narrative review.靶向活性氧和脂肪酸氧化调节肿瘤相关巨噬细胞:叙述性综述。
Front Immunol. 2023 Jul 21;14:1224443. doi: 10.3389/fimmu.2023.1224443. eCollection 2023.
多视角比较原发性结直肠癌和肝转移瘤的免疫微环境。
J Transl Med. 2022 Oct 4;20(1):454. doi: 10.1186/s12967-022-03667-2.
4
Role of CD68 in tumor immunity and prognosis prediction in pan-cancer.CD68 在泛癌中的肿瘤免疫和预后预测中的作用。
Sci Rep. 2022 May 12;12(1):7844. doi: 10.1038/s41598-022-11503-2.
5
CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity.CD206+ 肿瘤相关巨噬细胞交叉呈递肿瘤抗原并驱动抗肿瘤免疫。
JCI Insight. 2022 Jun 8;7(11):e155022. doi: 10.1172/jci.insight.155022.
6
CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate.CD36,一种信号受体和脂肪酸转运蛋白,调节免疫细胞代谢和命运。
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20211314. Epub 2022 Apr 19.
7
HMGB1 Promotes Lymphangiogenesis through the Activation of RAGE on M2 Macrophages in Laryngeal Squamous Cell Carcinoma.HMGB1 通过激活 M2 巨噬细胞上的 RAGE 促进喉鳞状细胞癌中的淋巴管生成。
Dis Markers. 2022 Mar 4;2022:4487435. doi: 10.1155/2022/4487435. eCollection 2022.
8
Effect of Early-Stage Human Breast Carcinoma on Monocyte Programming.早期人类乳腺癌对单核细胞编程的影响。
Front Oncol. 2022 Feb 14;11:800235. doi: 10.3389/fonc.2021.800235. eCollection 2021.
9
Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.自噬依赖性 HMGB1 的非经典分泌促进胶质母细胞瘤对替莫唑胺的化疗敏感性通过巨噬细胞 M1 样极化。
J Exp Clin Cancer Res. 2022 Feb 22;41(1):74. doi: 10.1186/s13046-022-02291-8.
10
Hyperglycemia Induces Inflammatory Response of Human Macrophages to CD163-Mediated Scavenging of Hemoglobin-Haptoglobin Complexes.高血糖诱导人巨噬细胞对血红蛋白-触珠蛋白复合物的 CD163 介导的清除作用产生炎症反应。
Int J Mol Sci. 2022 Jan 26;23(3):1385. doi: 10.3390/ijms23031385.